Document is current
Any future updates will be listed below
-
Authors
Bernstock, Joshua D. https://orcid.org/0000-0002-7814-3867
Mehari, Mulki
E. Gerstl, Jakob V.
Meredith, David M.
Valdes, Pablo A.
Heesen, Philip
Ambati, Vardhaan S. https://orcid.org/0000-0003-0074-9217
Krishna, Saritha
Chen, Jason A.
Arora, Harshit
Johnston, Benjamin R. https://orcid.org/0000-0002-6456-3908
Negussie, Mikias https://orcid.org/0000-0001-6060-6926
Grieco, Kristina
Nava Gonzales, Cesar
Dada, Abraham https://orcid.org/0000-0002-2125-7011
Lebouille-Veldman, Anna B.
Kabir, Aymen
Spanehl, Lennard https://orcid.org/0009-0009-9419-7302
Kaur, Jasleen
Oten, Sena
Sibih, Youssef E. https://orcid.org/0000-0002-0839-5428
Mekary, Rania A. https://orcid.org/0000-0003-1636-0759
Daniel, Andy
de Groot, John Frederick https://orcid.org/0000-0003-1454-6461
Izzy, Saef https://orcid.org/0000-0002-2822-6736
Gessler, Florian A.
Stone, Scellig https://orcid.org/0000-0002-4546-6790
Arnaout, Omar
Lu, Yi https://orcid.org/0000-0001-8180-8578
Choi, Bryan D.
Hall, Matthew D.
Mehta, Minesh P. https://orcid.org/0000-0002-4812-5713
Odia, Yazmin https://orcid.org/0000-0003-3602-3899
Friedman, Gregory K. https://orcid.org/0000-0002-6653-7420
Chiocca, E. A. https://orcid.org/0000-0001-5183-1670
Peruzzi, Pier Paolo https://orcid.org/0000-0001-5034-2963
Smith, Timothy R.
Hervey-Jumper, Shawn L. https://orcid.org/0000-0003-4699-260X
- License Information
-
More Information
Article History
Received: 9 December 2024
Accepted: 29 April 2025
First Online: 15 May 2025
Competing interests
: The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. Joshua D. Bernstock has an equity position in Treovir Inc. and UpFront Diagnostics. Dr. Bernstock is also a cofounder of Centile Bioscience and is on the NeuroX1 and QV Bioelectronics scientific advisory boards. Jason A. Chen is a cofounder and holds equity in Verge Genomics. Dr. Chen is also an advisor and holds equity in Gravity Medical Technology. Florian A. Gessler received honoraria from Signus, BBraun, Aesculap, and AstraZeneca. Gregory K. Friedman is supported by Eli Lilly and Company and Pfizer through contracts to UAB. Dr. Smith reports being a cofounder and equity holder of PheBe Health Inc.
